Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10059016HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10060330HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10060334HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10060337HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10060323HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10060338HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10059001HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10059017HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10060332HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10060339HBVENSG00000163631.19protein_codingALBNoNo213P02768
TCGA Plot Options
Drug Information
GeneALB
DrugBank IDDB06713
Drug NameNorelgestromin
Target IDBE0000530
UniProt IDP02768
Regulation Type
PubMed IDs12586319
CitationsHammond GL, Abrams LS, Creasy GW, Natarajan J, Allen JG, Siiteri PK: Serum distribution of the major metabolites of norgestimate in relation to its pharmacological properties. Contraception. 2003 Feb;67(2):93-9.
GroupsApproved; Investigational
Direct ClassificationEstrane steroids
SMILES[H][C@@]12CC[C@@](O)(C#C)[C@@]1(CC)CC[C@]1([H])[C@@]3([H])CCC(C=C3CC[C@@]21[H])=NO
Pathways
PharmGKB
ChEMBLCHEMBL1200807